11 min
Shared Decision-Making in Acute Myeloid Leukemia CANCER BUZZ
-
- Science
Caring for patients with acute myeloid leukemia (AML) depends on many factors and can vary as much as the patients themselves. As such, shared decision-making—those collaborative conversations between patient and physician that guide the treatment trajectory—are critical to align goals and help determine what’s best for each patient.
Due to the challenges COVID-19 presents for immune-compromised individuals, clinicians are having more complex discussions with their patients diagnosed with AML—including how to proceed with the COVID-19 vaccine and booster shot.
Guests:
Jonathan Abbas, MD
Director of Acute Leukemia Program
Tennessee Oncology
Ehab Atallah, MD
Professor of Medicine and Section Head of Hematological Malignancies
Medical College of Wisconsin
Catherine Lai, MD, MPH
Director of Leukemia
Georgetown University Medical Center
Related Content
Podcasts:
• What Comes Next for Telehealth? • [PODCAST] Ep 66: CLL, COVID-19, and Why Patient Registries Matter • [VIDEO PODCAST] Ep 02: Myeloma Care Strategies & COVID-19 • [VIDEO PODCAST] Ep 04: Chronic Lymphocytic Leukemia: Navigating Uncertainty • [PODCAST] Ep 57: COVID-19 Challenges: Managing Patients with CLL Webinars:
• Returning to Practice in the Post-COVID-19 Era: Hematology Disease Education • The COVID-19 Vaccine for Patients with CLL and Other Cancers • Multiple Myeloma Dispensing Models Six-Part Webinar Series • Supporting the Patient Journey: A Closer Look at Adult ALL Publications:
• MRD Testing Implementation Roadmap • Multidisciplinary Multiple Myeloma Care: Models of Quality Improvement Oncol Issues. 2021;36(2):50-61. • Multiple Myeloma Dispensing Models: Effective Practices to Improve Patient Care & the Patient Experience • Multidisciplinary Acute Lymphocytic Leukemia Care: Models of Quality Improvement [Oncology Issues]
This podcast is produced as part of the “Returning to Practice in the Post-COVID-19 Era: Hematology Disease Education” program.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.
Caring for patients with acute myeloid leukemia (AML) depends on many factors and can vary as much as the patients themselves. As such, shared decision-making—those collaborative conversations between patient and physician that guide the treatment trajectory—are critical to align goals and help determine what’s best for each patient.
Due to the challenges COVID-19 presents for immune-compromised individuals, clinicians are having more complex discussions with their patients diagnosed with AML—including how to proceed with the COVID-19 vaccine and booster shot.
Guests:
Jonathan Abbas, MD
Director of Acute Leukemia Program
Tennessee Oncology
Ehab Atallah, MD
Professor of Medicine and Section Head of Hematological Malignancies
Medical College of Wisconsin
Catherine Lai, MD, MPH
Director of Leukemia
Georgetown University Medical Center
Related Content
Podcasts:
• What Comes Next for Telehealth? • [PODCAST] Ep 66: CLL, COVID-19, and Why Patient Registries Matter • [VIDEO PODCAST] Ep 02: Myeloma Care Strategies & COVID-19 • [VIDEO PODCAST] Ep 04: Chronic Lymphocytic Leukemia: Navigating Uncertainty • [PODCAST] Ep 57: COVID-19 Challenges: Managing Patients with CLL Webinars:
• Returning to Practice in the Post-COVID-19 Era: Hematology Disease Education • The COVID-19 Vaccine for Patients with CLL and Other Cancers • Multiple Myeloma Dispensing Models Six-Part Webinar Series • Supporting the Patient Journey: A Closer Look at Adult ALL Publications:
• MRD Testing Implementation Roadmap • Multidisciplinary Multiple Myeloma Care: Models of Quality Improvement Oncol Issues. 2021;36(2):50-61. • Multiple Myeloma Dispensing Models: Effective Practices to Improve Patient Care & the Patient Experience • Multidisciplinary Acute Lymphocytic Leukemia Care: Models of Quality Improvement [Oncology Issues]
This podcast is produced as part of the “Returning to Practice in the Post-COVID-19 Era: Hematology Disease Education” program.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.
11 min